| In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2 D Prasanth, M Murahari, V Chandramohan, SP Panda, LR Atmakuri, ... Journal of Biomolecular Structure and Dynamics 39 (13), 4618-4632, 2021 | 100 | 2021 |
| An update on Drug Repurposing: Re-written saga of the drug’s fate HS Gns, GR Saraswathy, M Murahari, M Krishnamurthy Biomedicine & Pharmacotherapy 110, 700-716, 2019 | 93 | 2019 |
| Complexation of phytochemicals with cyclodextrin derivatives–An insight V Suvarna, P Gujar, M Murahari Biomedicine & Pharmacotherapy 88, 1122-1144, 2017 | 68 | 2017 |
| Current overview on the clinical update of Bcl-2 anti-apoptotic inhibitors for cancer therapy V Suvarna, V Singh, M Murahari European journal of pharmacology 862, 172655, 2019 | 51 | 2019 |
| Inclusion complexation of etodolac with hydroxypropyl-beta-cyclodextrin and auxiliary agents: formulation characterization and molecular modeling studies AP Sherje, V Kulkarni, M Murahari, UY Nayak, P Bhat, V Suvarna, ... Molecular pharmaceutics 14 (4), 1231-1242, 2017 | 48 | 2017 |
| Phytochemicals and PI3K inhibitors in cancer–An insight V Suvarna, M Murahari, T Khan, P Chuabey, P Sangave Frontiers in Pharmacology 8, 916, 2017 | 35 | 2017 |
| Acridone-pyrimidine hybrids-design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies M Murahari, KV Prakash, GJ Peters, YC Mayur European journal of medicinal chemistry 139, 961-981, 2017 | 33 | 2017 |
| Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors M Murahari, V Mahajan, S Neeladri, MS Kumar, YC Mayur Bioorganic Chemistry 86, 583-597, 2019 | 26 | 2019 |
| Inclusion complexes of Nateglinide with HP–β–CD and L-arginine for solubility and dissolution enhancement: Preparation, characterization, and Molecular Docking Study V Suvarna, A Kajwe, M Murahari, GV Pujar, BK Inturi, AP Sherje Journal of Pharmaceutical Innovation 12 (2), 168-181, 2017 | 24 | 2017 |
| Identification and usage of fluorescent probes as nanoparticle contrast agents in detecting cancer MS Murahari, MC Yergeri Current pharmaceutical design 19 (25), 4622-4640, 2013 | 22 | 2013 |
| Design, synthesis, biological evaluation, molecular docking and QSAR studies of 2, 4-dimethylacridones as anticancer agents M Murahari, PS Kharkar, N Lonikar, YC Mayur European journal of medicinal chemistry 130, 154-170, 2017 | 20 | 2017 |
| Host-guest interaction study of Efavirenz with hydroxypropyl‑β‑cyclodextrin and l‑arginine by computational simulation studies: Preparation and characterization of … V Suvarna, S Thorat, U Nayak, A Sherje, M Murahari Journal of Molecular Liquids 259, 55-64, 2018 | 17 | 2018 |
| Study on effect of L-arginine on solubility and dissolution of Zaltoprofen: Preparation and characterization of binary and ternary cyclodextrin inclusion complexes AP Sherje, F Patel, M Murahari, V Suvarna, K Patel Chemical physics letters 694, 120-128, 2018 | 17 | 2018 |
| Improved treatment efficacy of risedronate functionalized chitosan nanoparticles in osteoporosis: formulation development, in vivo, and molecular modelling studies S Santhosh, D Mukherjee, J Anbu, M Murahari, BV Teja Journal of Microencapsulation 36 (4), 338-355, 2019 | 16 | 2019 |
| Design of metronidazole derivatives and flavonoids as potential non-nucleoside reverse transcriptase inhibitors using combined ligand-and structure-based approaches PF Cutinho, J Roy, A Anand, R Cheluvaraj, M Murahari, HSV Chimatapu Journal of Biomolecular Structure and Dynamics 38 (6), 1626-1648, 2020 | 13 | 2020 |
| In silico screening of therapeutic potentials from Strychnos nux-vomica against the dimeric main protease (Mpro) structure of SARS-CoV-2 B Kumar, P Parasuraman, TPK Murthy, M Murahari, V Chandramohan Journal of Biomolecular Structure and Dynamics, 1-19, 2021 | 12 | 2021 |
| Current overview on the usage of poly (ADP-ribose) polymerase (PARP) inhibitors in treating cancer M Swamy Murahari, M C Yergeri Clinical Cancer Drugs 1 (2), 127-148, 2014 | 10 | 2014 |
| In-silico strategies of some selected phytoconstituents from Melissa officinalis as SARS CoV-2 main protease and spike protein (COVID-19) inhibitors D Prasanth, M Murahari, V Chandramohan, G Bhavya, A Lakshmana Rao, ... Molecular Simulation 47 (6), 457-470, 2021 | 9 | 2021 |
| Structure based pharmacophore modelling approach for the design of azaindole derivatives as DprE1 inhibitors for tuberculosis KB Suma, A Kumari, D Shetty, E Fernandes, DV Chethan, J Jays, ... Journal of Molecular Graphics and Modelling 101, 107718, 2020 | 9 | 2020 |
| Enzyme inhibitory function and phytochemical profile of Inula discoidea using in vitro and in silico methods E Bursal, MA Yılmaz, E Izol, F Türkan, MN Atalar, M Murahari, A Aras, ... Biophysical Chemistry 277, 106629, 2021 | 8 | 2021 |
vasanti suvarnaDr. Bhanuben Nanavati College of Pharmacy, MumbaiVerified email at bncp.ac.in
